Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Recombinant Human Erythropoietin, Following a Switch From Erythropoietin-stimulating Agents
Brief Summary: The purpose of this multi-center event-driven study in participants with anemia associated with chronic kidney disease (CKD) to evaluate the safety and efficacy of daprodustat.


Options:
A: Arm Label: Daprodustat; Type: EXPERIMENTAL; Interventions: Drug: Daprodustat, Drug: Placebo, Drug: Iron therapy | Arm Label: rhEPO; Type: ACTIVE_COMPARATOR; Interventions: Drug: rhEPO, Drug: Placebo, Drug: Iron therapy | Intervention Type: DRUG; Name: Daprodustat; Assigned to Arm(s): Daprodustat | Intervention Type: DRUG; Name: rhEPO; Assigned to Arm(s): rhEPO | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Daprodustat, rhEPO | Intervention Type: DRUG; Name: Iron therapy; Assigned to Arm(s): Daprodustat, rhEPO
B: Arm Label: Daprodustat; Type: EXPERIMENTAL; Interventions: Drug: Daprodustat small, Drug: Daprodustat large, Drug: Darbepoetin alfa placebo | Arm Label: Darbepoetin alfa; Type: ACTIVE_COMPARATOR; Interventions: Drug: Daprodustat small placebo, Drug: Daprodustat large placebo, Drug: Darbepoetin alfa | Intervention Type: DRUG; Name: Daprodustat small; Assigned to Arm(s): Daprodustat | Intervention Type: DRUG; Name: Daprodustat small placebo; Assigned to Arm(s): Darbepoetin alfa | Intervention Type: DRUG; Name: Daprodustat large; Assigned to Arm(s): Daprodustat | Intervention Type: DRUG; Name: Daprodustat large placebo; Assigned to Arm(s): Darbepoetin alfa | Intervention Type: DRUG; Name: Darbepoetin alfa; Assigned to Arm(s): Darbepoetin alfa | Intervention Type: DRUG; Name: Darbepoetin alfa placebo; Assigned to Arm(s): Daprodustat
C: Arm Label: ASP1517 Low dose group; Type: EXPERIMENTAL; Interventions: Drug: roxadustat | Arm Label: ASP1517 Middle dose group; Type: EXPERIMENTAL; Interventions: Drug: roxadustat | Arm Label: ASP1517 High dose group; Type: EXPERIMENTAL; Interventions: Drug: roxadustat | Arm Label: Darbepoetin group; Type: ACTIVE_COMPARATOR; Interventions: Drug: darbepoetin alfa | Intervention Type: DRUG; Name: roxadustat; Assigned to Arm(s): ASP1517 High dose group, ASP1517 Low dose group, ASP1517 Middle dose group | Intervention Type: DRUG; Name: darbepoetin alfa; Assigned to Arm(s): Darbepoetin group
D: Arm Label: Molidustat (BAY 85-3934)(25mg); Type: EXPERIMENTAL; Interventions: Drug: Molidustat (BAY 85-3934) | Arm Label: Molidustat (BAY 85-3934)(50mg); Type: EXPERIMENTAL; Interventions: Drug: Molidustat (BAY 85-3934) | Arm Label: Molidustat (BAY 85-3934) (75mg); Type: EXPERIMENTAL; Interventions: Drug: Molidustat (BAY 85-3934) | Arm Label: Molidustat (BAY 85-3934) (150mg); Type: EXPERIMENTAL; Interventions: Drug: Molidustat (BAY 85-3934) | Arm Label: Epoetin alfa/beta; Type: ACTIVE_COMPARATOR; Interventions: Biological: Epoetin alfa/beta | Intervention Type: DRUG; Name: Molidustat (BAY 85-3934); Assigned to Arm(s): Molidustat (BAY 85-3934) (150mg), Molidustat (BAY 85-3934) (75mg), Molidustat (BAY 85-3934)(25mg), Molidustat (BAY 85-3934)(50mg) | Intervention Type: BIOLOGICAL; Name: Epoetin alfa/beta; Assigned to Arm(s): Epoetin alfa/beta

Answer: A